Does one of the numerous experimental therapies improve all-cause mortality in adult patients admitted to intensive care for severe community-acquired pneumonia who require organ support?
Patient Type
COVID, Immunosuppression
INTERVENTION Type
Nonpharmacologic
GROUP A
2 doses of convalescent plasma
GROUP B
No transfusion
INCLUSION CRITERIA
COVID +
over 18 years old,
immunosuppressed
INCLUSION TIME LIMIT
-
EXCLUSION CRITERIA
14 days have passed since hospital admission
48 hours have passed since admission to intensive care
Call your research coordinator #20064 - #20065 - #20093
Une équipe passionnée - au service des patients et du savoir
